Successful treatment of empyema thoracis with human recombinant deoxyribonuclease

59Citations
Citations of this article
13Readers
Mendeley users who have this article in their library.

Abstract

Fibrinolytic enzymes, particularly streptokinase, are now widely used to treat empyema thoracis. Recent in vitro evidence suggests that streptokinase has no effect on pus viscosity but that deoxyribonuclease (DNase) reduces the viscosity of pus. We report the first use of human recombinant DNase given intrapleurally to treat an empyema which had not resolved after standard treatment with streptokinase.

Cite

CITATION STYLE

APA

Simpson, G., Roomes, D., & Reeves, B. (2003). Successful treatment of empyema thoracis with human recombinant deoxyribonuclease. Thorax, 58(4), 365–366. https://doi.org/10.1136/thorax.58.4.365

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free